Cough and cold medicines for infants are a placebo that can kill, according to a Calgary pediatrician.
Dr. Roxanne Goldade says Thursday’s voluntary recall of cough and cold medicines for babies under two is a smart move, and not an over-reaction by the drug industry.
A U.S. study found the medicines were associated with 120 overdose deaths since the late 1960’s, and close to 1,500 emergency room visits over the last two years.
Goldade says research now proves cough suppressants and decongestants don’t work in infants. She says they’re a “placebo” that satisfy a parent’s desire for a quick fix, but don’t actually help a sick child.
She says more study and better labeling is required, if these medications continue to be sold to children over 2.
The affected brands include Tylenol Cold, Benylin and Dimetapp for infants.
The Non-Prescription Drug Association says the medications are safe when used appropriately, but the industry is erring on the side of caution.
“The data being reviewed has revealed a pattern of misuse that is concerning and since there are questions, primarily focused on safety, it seems like the right thing to do,” says spokesman Gerry Hetherington.
While some parents may be sad to see these products pulled from shelves after 30 years on the market, many pediatricians maintain the best advice is to let a cold run its course, sniffles and all.
“Relax, the body is going to take care of most things. If the child is getting worse or they look unwell, then they have to see a doctor,” says pediatrician Dr. Yoel Abells.
Health Canada has issued an advisory warning parents not to use these medications in infants, unless instructed by a doctor.
In the United States, some doctors have launched a petition to ban cold medicines in all children under the age of 6.
Comments
Want to discuss? Please read our Commenting Policy first.